Neurologic
& Mental Health

Exposure-Oriented Connection

Clarifying mycotoxin exposure within broader neurologic and mental health presentations

Evaluates mycotoxin exposure via both inhalational and dietary routes.

Many patients with a history of mold or water-damaged building exposure show up with a mix of symptoms—like brain fog, mood changes, fatigue, and sleep problems—that are hard to pin down to one cause.[1,2,3] Because these symptoms can overlap with stress, anxiety, or other common conditions, potential contributing factors may not be fully explored, leaving patients without clear answers for a long time. [2,11]

MycoTOX Profile evaluates mycotoxin exposure via both inhalational and dietary routes.

Explore the MycoTOX Profile

When to Consider MycoTOX Profile

What the MycoTOX Profile Measures

Clinical Applications & Evidence Context

How the MycoTOX Profile Supports Clinical Reasoning

How to Order the MycoTOX Profile

References

When to Consider the MycoTOX Profile

Neurologic & Mental Health – Exposure-Oriented Connection1

Cognitive & Executive Complaints: Patients presenting with brain fog, word-finding difficulty, impaired memory, or slowed processing—particularly when fluctuating or non-focal in character. [1,3,7]

Motor & Coordination Changes:Subtle tremor, balance instability, gait irregularity, or fine motor difficulty with no clear structural etiology.[4,5,8,9]

Neuropsychiatric & Mood Symptoms: Anxiety, depressive symptoms, irritability, or emotional lability that may not fully respond to standard interventions and co-occur with somatic or environmental triggers.[1,4,9,11]

Neuroimmune / Multisystem Pattern: Chronic fatigue, post-exposure symptom flares, pain amplification, or relapsing-remitting presentations overlapping with cognitive and mood domains. [1,3,10,11]

Sensory & Headache Syndromes: Recurrent headaches, migraine-like episodes, photophobia, tinnitus, or sensory hypersensitivity, especially when temporally associated with exposure history. [1,3,7]

Known or Suspected Mold Exposure: History of residence or work in a water-damaged building, or suspected dietary mycotoxin exposure, with any of the above neurologic or neuropsychiatric symptom clusters.[2,6]

Analyte ClassEveryday Exposure SourcesNeurologic Relevance
AflatoxinsPeanuts, tree nuts, corn, and other commodities with fungal contamination [4]Associated with oxidative stress and hepatic-CNS interactions; may contribute to systemic inflammatory burden [1,4]
Ochratoxin AGrain-based foods, coffee, dried fruits, spices; indoor mold environments [8]Linked to dopaminergic dysfunction, mitochondrial impairment, and protein aggregation relevant to neurodegeneration [5,8,9]
Trichothecenes (e.g., Deoxynivalenol)Contaminated grains, wheat, corn, barley; water-damaged building materials [4,7]Associated with oxidative stress, neuronal injury, and immune modulation relevant to cognitive and mood pathways [1,7]
ZearalenoneGrains and grain-derived products; water-damaged building environments [4]Exhibits endocrine-disrupting properties; may intersect with neuroendocrine and mood-regulatory pathways [4,11]
Other important mycotoxins (e.g., Gliotoxin)Indoor mold environments, particularly Aspergillus and Stachybotrys species [2,6]Associated with immune modulation, blood-brain barrier interactions, and neuroimmune activation [2,3,6]

ConditionClinical Encapsulation
Depression & Anxiety DisordersInflammatory signaling, oxidative stress, and neuroimmune activation—all associated with mycotoxin exposure—overlap with biologic pathways implicated in mood and anxiety symptom expression, supporting use of MycoTOX as a contextual exposure marker in treatment-resistant or environmentally triggered presentations. [1,3,7,9,10,11]
Autism Spectrum DisorderGut-brain axis disruption, mitochondrial dysfunction, and immune dysregulation are active research areas in ASD biology, and may intersect with mycotoxin exposure pathways in subsets of patients with multisystem or sensory-behavioral presentations. [1,4,8,11]
Parkinson’s DiseaseOchratoxin A and fumonisin exposure have been associated in experimental settings with dopaminergic dysfunction, impaired autophagy, and protein aggregation relevant to Parkinsonian neurodegeneration. [4,5,8,9]
Alzheimer’s Disease / DementiaNeuroinflammation, oxidative stress, and environmental toxin exposure represent emerging research areas in Alzheimer’s pathophysiology; mycotoxin biomonitoring may provide one biologic data point within a broader neurodegenerative clinical workup. [1,6,7,8]
Chronic Fatigue & Neuroimmune SyndromesRelapsing fatigue, and cognitive slowing associated with neuroimmune activation may be contextually supported by mycotoxin exposure data in patients with overlapping environmental triggers. [1,3,8,11]

Adds Exposure Context

Adds mycotoxin data that may be considered alongside water-damaged, occupational, or food exposure history. [2,4,6,11]

Mechanistic Pathway Context

Detection of specific mycotoxin classes may help contextualize biologically plausible mechanisms—including oxidative stress, mitochondrial dysfunction, and neuroimmune activation—that are relevant to the patient’s presenting symptom profile. [1,3,4,7,8]

Multi-Route Exposure Assessment

MycoTOX evaluates mycotoxin exposure via both inhalational (water-damaged environments) and dietary routes, broadening the clinical utility of exposure history interpretation. [2,4,6]

How to Order

Neurologic & Mental Health – Exposure-Oriented Connection1

To order the MycoTOX Profile, register for a portal account. Specimen collection kits and requisition forms are available through your account portal. For clinical support or interpretation questions, contact our clinical education team.

Order the MycoTOX Profile

Explore Other Neurologic &
Mental Health Testing
Lenses:

Exposure-Oriented
Connection
Metabolic
Connection
Gut-Brain
Connection
Food-Related
Connection
Download | Printable PDF

This webpage is intended for licensed healthcare professionals and is for informational and educational purposes only. The test results are not intended to diagnose, treat, cure, or prevent disease. All clinical interpretation should be done by a qualified healthcare professional in the context of the individual patient. Statements regarding associations between health symptoms and conditions do not constitute diagnostic claims.

References

  1. Ratnaseelan AM, Tsilioni I, Theoharides TC. Effects of mycotoxins on neuropsychiatric symptoms and immune processes. Clin Ther. 2018;40(6):903-917.
  2. Ehsanifar M, et al. Mold and mycotoxin exposure and brain disorders. J Integr Neurosci. 2023;22(6):137.
  3. Harding CF, et al. Mold inhalation causes innate immune activation and cognitive and emotional dysfunction. Brain Behav Immun. 2020;86:110-122.
  4. Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem Toxicol. 2013;60:218-237.
  5. Serrano-Civantos M, et al. Ochratoxin A and Parkinson’s disease: a systematic review of molecular and clinical evidence. Arch Toxicol. 2025.
  6. Arce-Lopez B, et al. Biomonitoring of mycotoxins in patients with neurodegenerative diseases. Toxins (Basel). 2021;13(7):477.
  7. Pestka JJ. Deoxynivalenol-induced oxidative stress and immune modulation. Toxins (Basel). 2010;2(6):1300-1317.
  8. Malir F, Ostry V, Pfohl-Leszkowicz A, Novotna E. Ochratoxin A: 50 years of research. Toxins (Basel). 2016;8(7):191.
  9. Frohlich AA, et al. Neurochemical effects of mycotoxins: dopamine and serotonin pathways. Mycotoxin Res. 2015;31(3):127-140.
  10. Miller JD, McMullin DR. Fungal secondary metabolites as modulators of immune function. J Appl Microbiol. 2014;117(4):952-962.
  11. Ehsanifar M, Gholami A, Pahnavar N, Shenasi R, Golmohammadi M. Exposure to mycotoxins: neurological disorders and psychiatric manifestations. OBM Neurobiol. 2026;10:1-21. doi:10.21926/obm.neurobiol.2601322.

Not sure which testing path fits your patient?

Our clinical team helps you choose the right panel and interpret results with confidence.

Talk to our clinical team